Malaysia approves conditional registration for China’s CoronaVac vaccine

PUTRAJAYA (THE STAR/ASIA NEWS NETWORK) : Malaysia has approved the conditional registration of the CoronaVac Covid-19 vaccine, its health ministry said.

Health director-general Noor Hisham Abdullah said in a statement the decision was made during the 356th Drug Control Authority meeting on Friday (April 23).

The product is developed by China’s Sinovac Life Sciences.

Pharmaniaga LifeScience (PLS) is carrying out the fill-and-finish process of the vaccine.

Before this, Malaysia has also given conditional approval to the finished doses of the CoronaVac vaccine produced by Sinovac in China.

Dr Noor Hisham said the deal for PLS to carry out the fill-and-finish process of the CoronaVac vaccine is an achievement for Malaysia, which has been relying on imported vaccine and plasma products.

The vaccine is developed by China's Sinovac Life Sciences.
The vaccine is developed by China’s Sinovac Life Sciences.PHOTO: EPA-EFE

“Hopefully, this development can spur the growth of the local pharmaceutical industry,” he said.

In January, PLS signed an agreement with Sinovac to import 14 million doses of Covid-19 vaccines, which will then be “filled and finished” at its facilities in Puchong, Selangor.

Fill-and-finish is the process of filling vials with vaccines and finishing with the packaging of the medicine for distribution.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s